SB 842
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| BALLARD & TIGHE, Publishers | Lobbied on it | BALLARD & TIGHE, Publishers named SB 842 in 3 lobbying reports. | 3 reports |
| Purdue Pharma L.P. | Lobbied on it | Purdue Pharma L.P. named SB 842 in 3 lobbying reports. | 3 reports |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named SB 842 in 1 lobbying report. | 1 report |
| Cephalon, Inc. | Lobbied on it | Cephalon, Inc. named SB 842 in 1 lobbying report. | 1 report |
| GSK | Lobbied on it | GSK named SB 842 in 1 lobbying report. | 1 report |
| RELX Inc. and Its Subsidiaries | Lobbied on it | RELX Inc. and Its Subsidiaries named SB 842 in 1 lobbying report. | 1 report |
| Schering Corporation | Lobbied on it | Schering Corporation named SB 842 in 1 lobbying report. | 1 report |
| Sunovion Pharmaceuticals Inc. | Lobbied on it | Sunovion Pharmaceuticals Inc. named SB 842 in 1 lobbying report. | 1 report |
| Instructional materials: accessibility. | Source records | SB 842 has an explicit source reference to Instructional materials: accessibility.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…